Vol. 14 Issue 1

Clinical Feature: Why Advocacy is Important to a Medical Specialty Organization

In the strictest sense, “advocacy” is defined as the act or process of supporting a cause. With that as the basis of our discussion, why is advocacy important to a medical specialty organization such as the National Lipid Association (NLA)? The NLA’s mission statement includes comments on... more

Guest Editorial: Bringing the Nation Together to Save a Million Hearts by 2017

Every 39 seconds, a U.S. adult dies from cardiovascular disease (CVD),1  the nation’s top killer and a leading cause of disability for Americans both young and old. We spend about 1 out of 6 healthcare dollars on this disease each year — an estimated nearly $320 billion in healthcare expenses... more

EBM Tools for Practice: Beyond the Guidelines: Application of Trial Data to Individual Patients by Focusing on Explanatory vs. Pragmatic Trials

This edition of the LipidSpin is devoted to guidelines vs. guidance. We all strive to practice evidence-based medicine (EBM) and our understanding of science has moved forward at a quick pace. Multiple journals come out every week with new articles that advance medicine’s knowledge base. Large,... more

Lipid Luminations: New Evidence For Non-Statin Lipid-Lowering Medications

The American College of Cardiology/American Heart Association (ACC/AHA) Blood Cholesterol Guideline recommends high-intensity statin therapy for high-risk patients to reduce the risk of major adverse cardiovascular events (MACE).1 Despite treatment with high-intensity statins, patients... more